0001209191-20-059157.txt : 20201118
0001209191-20-059157.hdr.sgml : 20201118
20201118170008
ACCESSION NUMBER: 0001209191-20-059157
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20201116
FILED AS OF DATE: 20201118
DATE AS OF CHANGE: 20201118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bondurant William
CENTRAL INDEX KEY: 0001792295
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36330
FILM NUMBER: 201325776
MAIL ADDRESS:
STREET 1: C/O CASTLIGHT HEALTH, INC.
STREET 2: 150 SPEAR STREET, SUITE 400
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CASTLIGHT HEALTH, INC.
CENTRAL INDEX KEY: 0001433714
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
IRS NUMBER: 261989091
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 150 SPEAR STREET
STREET 2: SUITE 400
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
BUSINESS PHONE: 415-671-4683
MAIL ADDRESS:
STREET 1: 150 SPEAR STREET
STREET 2: SUITE 400
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
FORMER COMPANY:
FORMER CONFORMED NAME: VENTANA HEALTH SERVICES, INC.
DATE OF NAME CHANGE: 20090831
FORMER COMPANY:
FORMER CONFORMED NAME: MARIA HEALTH INC
DATE OF NAME CHANGE: 20080429
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-11-16
0
0001433714
CASTLIGHT HEALTH, INC.
CSLT
0001792295
Bondurant William
C/O CASTLIGHT HEALTH, INC.
150 SPEAR STREET, SUITE 400
SAN FRANCISCO
CA
94105
0
1
0
0
Chief Financial Officer
Class B Common Stock
2020-11-16
4
M
0
1875
0.00
A
129784
D
Class B Common Stock
2020-11-16
4
M
0
3750
0.00
A
133534
D
Class B Common Stock
2020-11-16
4
M
0
3750
0.00
A
137284
D
Class B Common Stock
2020-11-16
4
M
0
9375
0.00
A
146659
D
Class B Common Stock
2020-11-16
4
M
0
8437
0.00
A
155096
D
Class B Common Stock
2020-11-16
4
M
0
52817
0.00
A
207913
D
Class B Common Stock
2020-11-16
4
M
0
56250
0.00
A
264163
D
Class B Common Stock
2020-11-17
4
S
0
48844
1.1391
D
215319
D
Restricted Stock Units (RSU)
2020-11-16
4
M
0
1875
0.00
D
Class B Common Stock
1875
1250
D
Restricted Stock Units (RSU)
2020-11-16
4
M
0
3750
0.00
D
Class B Common Stock
3750
3750
D
Restricted Stock Units (RSU)
2020-11-16
4
M
0
3750
0.00
D
Class B Common Stock
3750
8750
D
Restricted Stock Units (RSU)
2020-11-16
4
M
0
9375
0.00
D
Class B Common Stock
9375
21875
D
Restricted Stock Units (RSU)
2020-11-16
4
M
0
8437
0.00
D
Class B Common Stock
8437
25313
D
Restricted Stock Units (RSU)
2020-11-16
4
M
0
52817
0.00
D
Class B Common Stock
52817
211269
D
Restricted Stock Units (RSU)
2020-11-16
4
M
0
56250
0.00
D
Class B Common Stock
56250
243750
D
On November 16, 2020, these shares of Class B Common Stock were issued in settlement of the RSUs that vested on each of May 16, 2020, August 16, 2020 and November 16, 2020. Delivery of the shares in settlement of the RSUs that vested on May 16, 2020 and August 16, 2020 was deferred to November 16, 2020.
Includes 1,770 shares of Class B Common Stock acquired under the Issuer's employee stock purchase plan on August 31, 2020.
Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees.
Represents the weighted average sales price per share. The shares sold at prices ranging from $1.13 to $1.17 shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration.
1/4th of the RSUs vested on May 16, 2018, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. The underlying vested shares settled on November 16, 2020.
1/4th of the RSUs vested on August 16, 2018, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. The underlying vested shares settled on November 16, 2020.
1/16th of the RSUs vested on November 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. The underlying vested shares settled on November 16, 2020.
1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. The underlying vested shares settled on November 16, 2020.
1/16th of the RSUs vested on February 16, 2020, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. The underlying vested shares settled on November 16, 2020.
1/16th of the RSUs vest on May 16, 2020, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. The underlying vested shares settled on November 16, 2020.
/s/ Mary Ahern, by power of attorney
2020-11-18
EX-24.4_945841
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, that the undersigned hereby constitutes and
appoints Alex Shvartsman and Mary Ahern as his true and lawful attorney-in-fact
to:
(1) execute for and on behalf of the undersigned, in the undersigned's capacity
as a representative of Castlight Health, Inc. (the "Company"), any and all Form
ID, or Form 3, 4 or 5 reports and any amendments thereto required to be filed by
the undersigned in accordance with Section 16(a) of the Securities Exchange Act
of 1934 (the "Exchange Act") and the rules thereunder with respect to
transactions in the Company's securities;
(2) do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete and execute any such Form ID, or Form
3, 4 or 5 report and any amendments thereto and timely file such report with the
U.S. Securities and Exchange Commission and any stock exchange or similar
authority; and
(3) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney in-fact on behalf of the
undersigned, pursuant to this Power of Attorney, shall be in such form and shall
contain such terms and conditions as such attorney in-fact may approve in his or
her discretion.
The undersigned hereby grants to such attorney-in-fact full power and authority
to do and perform each and every act and thing whatsoever requisite, necessary,
and proper to be done in the exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as the undersigned might or could
do if personally present, with full power of substitution or revocation, hereby
ratifying and confirming all that such attorney-in-fact, or her/his substitute
or substitutes, shall lawfully do or cause to be done by virtue of this Power of
Attorney and the rights and powers herein granted. The undersigned acknowledges
that no such attorney in-fact, in serving in such capacity at the request of the
undersigned, is hereby assuming, nor is the Company hereby assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Form 3, 4 or 5 reports with respect to
the undersigned's holdings of and transactions in securities issued by the
Company, unless earlier revoked by the undersigned in a signed writing delivered
to the foregoing attorney in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of November 16, 2020.
/s/ Will Bondurant
Will Bondurant